Joint Statement on Clinical Trial Oversight in Canada

Joint Statement on Clinical Trial Oversight in Canada Health Canada (HC) and the Canadian Institutes of Health Research (CIHR), with the collaboration and participation of the Canadian Association of Research Ethics Boards (CAREB), recognize the urgent need to conduct clinical trials to evaluate the safety and efficacy of a drug, a vaccine or a medical device in treating, preventing, mitigating or diagnosing COVID-19. 2020-11-04 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetyCOVID-19pandemictreatingpreventingmitigating or diagnosing COVID-19Joint StatementClinical Trialconduct clinical trialssafety and efficacy of a drugsafety and efficacy of a vaccinesafety and efficacy of a medical device Joint Statement on Clinical Trial Oversight in CanadaHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/joint-statement-clinical-trial-oversight-canada.html Joint Statement on Clinical Trial Oversight in CanadaHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/annonces/declaration-commune-surveillance-essais-cliniques-canada.html

Health Canada (HC) and the Canadian Institutes of Health Research (CIHR), with the collaboration and participation of the Canadian Association of Research Ethics Boards (CAREB), recognize the urgent need to conduct clinical trials to evaluate the safety and efficacy of a drug, a vaccine or a medical device in treating, preventing, mitigating or diagnosing COVID-19.

Data and Resources

Similar records